Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05376267 · ClinicalTrials.gov registry record · NA

Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)

A NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
900
Enrollment target
20
Study locations

NCT05376267: Recruiting NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain, sponsored by University of Michigan.

NCT05376267 is a NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 900 participants, below the 1,446-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (38% lower). The trial reports 20 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05376267, a NA study of Cardiac Arrest, Out-Of-Hospital and Hypoxia-Ischemia, Brain, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
900 participants
Enrollment target
20
Study locations

Study Summary

This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that attain a good neurobehavioral recovery or may result in better recovery among the proportion already categorized as having a good outcome.

Primary Outcome

The VABS-3 score, designed to be administered to surviving children with any level of function including comatose status to age-appropriate neurobehavioral functioning, ranges from 20 to 140 with age-corrected standardized mean and standard deviation of 100 and 15, respectively. Deaths will be scored as 0 in this trial.

Interventions

  • DEVICE Therapeutic Hypothermia

Study Locations (20)

California

  • Memorial Health - Miller Children's and Women's Hospital of Long Beach - Long Beach
  • Children's Hospital of Los Angeles - Los Angeles
  • University of California Los Angeles (UCLA) Mattel Children's Hospital - Los Angeles
  • University of California - Oakland / UCSF Benoiff Children's Hospital Oakland - Oakland
  • Children's Hospital of Orange County - Orange
  • University of California, Davis - Sacramento
  • University of California - San Francisco (UCSF) Benioff Children's Hospital San Francisco - San Francisco
  • Stanford - Santa Clara

Illinois

  • Ann & Robert Lurie Children's Hospital of Chicago - Chicago
  • Comer Children's Hospital, University of Chicago - Chicago
  • Children's Hospital of Illinois - Peoria

Arizona

  • Phoenix Children's Hospital - Phoenix
  • Banner University Medical Center - Tucson - Tucson

Florida

  • University of Florida (UF) Health Shands Children's Hospital - Gainesville
  • University of Miami - Miami

Maryland

  • University of Maryland Children's Hospital - Baltimore
  • Johns Hopkins Medicine Children's Center - Baltimore

Alabama

  • University of Alabama at Birmingham / Children's of Alabama - Birmingham

Indiana

  • Riley Children's Health - Indianapolis

Iowa

  • University of Iowa, Carver College of Medicine - Iowa City

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2022-08-05
Est. Completion 2028-03-31
Phase NA
University of Michigan

1,327 total trials

What NCT05376267 shows while recruiting

NCT05376267 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,446-participant average among 5 other Cardiac Arrest, Out-Of-Hospital trials with a reported enrollment target (38% lower).

The record links to 3 conditions, with Cardiac Arrest, Out-Of-Hospital appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic Hypothermia is the first listed.

NCT05376267 names 20 study sites across 8 states, led by California, Illinois, Arizona.

Frequently Asked Questions

What is clinical trial NCT05376267 about?

NCT05376267 is a clinical study titled "Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)". This is a multicenter trial to establish the efficacy of cooling and the optimal duration of induced hypothermia for neuroprotection in pediatric comatose survivors of cardiac arrest. The study team hypothesizes that longer durations of cooling may improve either the proportion of children that att...

What is the current status of trial NCT05376267?

This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2022-08-05. Estimated completion is 2028-03-31.

What conditions does trial NCT05376267 study?

This clinical trial studies the following conditions: Cardiac Arrest, Out-Of-Hospital, Hypoxia-Ischemia, Brain, Hypothermia, Induced.

What interventions are being tested in trial NCT05376267?

The interventions under investigation include: Therapeutic Hypothermia (DEVICE).

Who is sponsoring clinical trial NCT05376267?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05376267 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrest, Out-Of-Hospital

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05376267, the US trial registry maintained by the National Library of Medicine. NCT05376267 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.